Information Journal Paper
APA:
CopyVAHDAT, L.T., PRUITT, B., & FABIAN, C.J.. (2009). PHASE II STUDY OF ERIBULIN MESYLATE, A HALICHONDRIN B ANALOG, IN PATIENTS WITH METASTATIC BREAST CANCER PREVIOUSLY TREATED WITH AN ANTHRACYCLINE AND A TAXANE. JOURNAL OF CLINICAL ONCOLOGY, 27(18), 2954-2961. SID. https://sid.ir/paper/672291/en
Vancouver:
CopyVAHDAT L.T., PRUITT B., FABIAN C.J.. PHASE II STUDY OF ERIBULIN MESYLATE, A HALICHONDRIN B ANALOG, IN PATIENTS WITH METASTATIC BREAST CANCER PREVIOUSLY TREATED WITH AN ANTHRACYCLINE AND A TAXANE. JOURNAL OF CLINICAL ONCOLOGY[Internet]. 2009;27(18):2954-2961. Available from: https://sid.ir/paper/672291/en
IEEE:
CopyL.T. VAHDAT, B. PRUITT, and C.J. FABIAN, “PHASE II STUDY OF ERIBULIN MESYLATE, A HALICHONDRIN B ANALOG, IN PATIENTS WITH METASTATIC BREAST CANCER PREVIOUSLY TREATED WITH AN ANTHRACYCLINE AND A TAXANE,” JOURNAL OF CLINICAL ONCOLOGY, vol. 27, no. 18, pp. 2954–2961, 2009, [Online]. Available: https://sid.ir/paper/672291/en